4.4 Review

Tissue Engineering and Regenerative Medicine: Recent Innovations and the Transition to Translation

期刊

TISSUE ENGINEERING PART B-REVIEWS
卷 19, 期 1, 页码 1-13

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/ten.teb.2012.0723

关键词

-

资金

  1. National Institutes of Health [R01EB02425, R01EB008722, R01AR056624]
  2. Veterans' Administration [I01RX000174, I01RX000700]
  3. Musculoskeletal Transplant Foundation (Junior Investigator Grant)
  4. Orthopedic Research and Education Foundation
  5. Penn Center for Musculoskeletal Disorders [P30AR050950]
  6. Penn Institute for Regenerative Medicine

向作者/读者索取更多资源

The field of tissue engineering and regenerative medicine (TERM) has exploded in the last decade. In this Year (or so) in Review, we highlight some of the high impact advances within the field over the past several years. Using the past as our guide and starting with an objective premise, we attempt so to identify recent hot topics and transformative publications within the field. Through this process, several key themes emerged: (1) tissue engineering: grafts and materials, (2) regenerative medicine: scaffolds and factors that control endogenous tissue formation, (3) clinical trials, and (4) novel cell sources: induced pluripotent stem cells. Within these focus areas, we summarize the highly impactful articles that emerged from our objective analysis and review additional recent publications to augment and expand upon these key themes. Finally, we discuss where the TERM field may be headed and how to monitor such a broad-based and ever-expanding community.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据